Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.

Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision history now shows a new revision entry v3.3.2 and removes the previous v3.2.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved a general site operating-status notice; the study details content remains the same.SummaryDifference0.3%

- Check42 days agoChange DetectedBoth screenshots depict the same Study Details page for NCT03792724 with only minor UI/layout refinements and no changes to the study design, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference1.0%

- Check78 days agoChange DetectedThe page now shows Revision: v3.1.0 and adds a phone number 34948255400; previous version Revision: v3.0.2 is removed.SummaryDifference0.0%

- Check92 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2; removed the minor UI element 'Back to Top'.SummaryDifference0.1%

Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.